Low-molecular-weight heparins in atrial fibrillation: clinical scenarios, limitations, and future perspectives
Atrial fibrillation (AF) is associated with a significantly increased risk of thromboembolic complications, including ischaemic stroke. Despite the dominant role of oral anticoagulants, low-molecular-weight heparins (LMWHs) are still used in selected clinical scenarios. The aim of this review was to summaris...